小动脉硬化

xiǎo dònɡ mài yìnɡ huà
  • arteriolosclerosis;arteriolopathy
小动脉硬化小动脉硬化
  1. 结论肾小球硬化是肾脏老化的特征性形态学变化,与小动脉硬化在发生、发展上有着相似之处。

    Conclusion Glomerulosclerosis is the characteristic morphological change in aging kidney which may share similar pathogenesis with arteriolosclerosis .

  2. 本文应用彩色多普勒超声技术对30例高血压及28例糖尿病患者的肾脏进行研究,将患者分为三期,即肾小动脉硬化期、肾功能不全代偿期和肾功能不全失代偿期。

    We had studied kidneys in 30 cases of hypertension and 28 cases of diabetes mellitus by color doppler flow imaging . The patients were divided into three groups : renal arteriolosclerosis stage , chronic renal insufficiency ( compensatory stage ) and chronic renal insufficiency ( incompensatory stage ) .

  3. 目的探讨拟诊高血压肾硬化(HN)患者的临床特征,以期提高对良性肾小动脉硬化症(BN)及类似疾病的认识。

    Objective To investigate the clinical and pathological characteristics of patients with clinically presumed hypertensive nephrosclerosis ( HN ) .

  4. 高血压肾小动脉硬化病人外周血单个核细胞中MMP-9及TGF-β1mRNA的表达

    Expressions of metalloproteinase-9 and transform growth factor - β _1 mRNA in peripheral blood monocytes in patients with hypertention and renal arteriolar sclerosis

  5. 脑梗死组不同脑区小动脉硬化程度。

    Arteriole sclerosis in various brain region in cerebral infarction group .

  6. 脑梗死患者脑内不同节段小动脉硬化程度差异的相关性

    Quantitative analysis of arteriolosclerosis between different arterioles in patients with cerebral infarction

  7. 黄芪固精饮治疗老年性良性肾小动脉硬化症30例临床观察

    Clinical Investigation on 30 Cases of Senile Benign Reno - Arteriolar sclerosis Treated by Huang Qi Gu Jing Yin

  8. 肾实质变薄的程度表明肾小动脉硬化,残存肾单位总数下降。

    The degree of the renal parenchyma thickness becoming thin showed renal arteriole sclerosis and the decreased number of remnant nephron .

  9. 目的探讨脑梗死后不同部位及不同外径脑小动脉硬化程度的差异。

    Objective To explore the difference in degree of sclerosis of cerebral arteriols at different sites and different diameters after cerebral infarction .

  10. 结论:纤溶活性和血、尿d二聚体水平变化在高血压肾小动脉硬化的发生发展中具有重要作用,可作为早期诊断的依据。

    Conclusions : abnormalities of fibrinolytic activity and D D level play an important role in hypertensive arteriolar nephrosclerosis and can be used as indicator for early diagnosis .

  11. 高血压性肾硬化患者血清中TIMP-1含量变化及意义氯沙坦对原发性高血压良性小动脉肾硬化血液流变性的影响

    The Relation between TIMP-1 and Hypertension Nephrosclerosis Effect of losartan on hemorrheology of hypertensive arteriolar nephrosclerosis

  12. 结果:CADASIL组白质及灰质小动脉的硬化指数明显高于对照组。

    Results : SI of CADASIL group was significantly higher than that of control group in both GM and WM .

  13. 冠状动脉分支硬化,如图所示高血压时小动脉分支硬化,管腔明显狭窄。

    The peripheral coronary arteries may undergo sclerosis , as seen here in an artery branch with a very small lumen , with chronic hypertension .

  14. 目的探讨血浆肾素活性(PRA)及醛固酮(ALD)水平在恶性高血压性小动脉性肾硬化诊断中的价值。

    Objective To study the diagnostic value of plasma renin activity ( PRA ) and aldosterone ( ALD ) in diagnosing malignant hypertensive arteriolar nephrosclerosis .

  15. 老年高血压病患者良性小动脉性肾硬化症危险因素分析

    A Study on Risk Factors of Benign Arteriolar Nephrosclerosis in Elderly Patients with Essential Hypertension

  16. 血浆肾素、醛固酮在恶性高血压性小动脉性肾硬化诊断中的临床研究

    The clinical study of plasma renin activity and aldosterone in diagnosing malignant hypertensive arteriolar nephrosclerosis

  17. 目的:观察伊贝沙坦对良性小动脉性肾硬化蛋白尿的效应。

    Objective : To observe the effect of irbesartan on proteinuria in benign arteriolar nephrosclerosis patients .

  18. 结论替米沙坦对良性小动脉性肾硬化所致肾损害的改善较氨氯地平为好。

    Conclusion Telmisartan has better efficacy than amlodipine in treatment of renal damage caused by benign arteriolar nephrosclerosis .